CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection

European Urology

Volumn 57, Issue 4, 2010, Pages 648-654

  Tilki, Derya ^a,c   Singer, Bernhard B ^b   Shariat, Shahrokh F ^d   Behrend, Andreas ^a   Fernando, Malkanthi ^e   Irmak, Ster ^b   Buchner, Alexander ^a   Hooper, Andrea T ^c   Stief, Christian G ^a   Reich, Oliver ^a   Ergün, Süleyman ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiogenesis; Bladder cancer; Tumor markers; Urine

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1;

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; CYSTITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ANTIGENS, CD; BLOTTING, WESTERN; CARCINOMA; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHI-SQUARE DISTRIBUTION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 77249084117     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.05.040     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Pagano F., Bassi P., Galetti T.P., et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145 (1991) 45-50
3. Prout Jr. G.R., Barton B.A., Griffin P.P., and Friedell G.H. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J Urol 148 (1992) 1413-1419
4. Karakiewicz P.I., Benayoun S., Zippe C., et al. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int 97 (2006) 997-1001
5. Babjuk M., Oosterlinck W., Sylvester R., Kaasinen E., Böhle A., and Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54 (2008) 303-314
6. Whelan P. Bladder cancer-contemporary dilemmas in its management. Eur Urol 53 (2008) 24-26
7. Lotan Y., and Roehrborn C.G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61 (2003) 109-118
8. van Rhijn B.W.G. Considerations on the use of urine markers for bladder cancer. Eur Urol 53 (2008) 880-881
9. Vrooman O.P.J., and Witjes J.A. Urinary markers in bladder cancer. Eur Urol 53 (2008) 909-916
10. Carmeliet P. Manipulating angiogenesis in medicine. J Intern Med 255 (2004) 538-561
11. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 3 (2003) 643-651
12. Dejana E., Spagnuolo R., and Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 86 (2001) 308-315
13. Ergun S., Kilic N., Ziegeler G., et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 5 (2000) 311-320
14. Oliveira-Ferrer L., Tilki D., Ziegeler G., et al. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 64 (2004) 8932-8938
15. Tilki D., Irmak S., Oliveira-Ferrer L., et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene 25 (2006) 4965-4974
16. Kilic N., Oliveira-Ferrer L., Wurmbach J.H., et al. Pro-angiogenic signaling by the endothelial presence of CEACAM1. J Biol Chem 280 (2005) 2361-2369
17. Kilic N., Oliveira-Ferrer L., Neshat-Vahid S., et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 110 (2007) 4223-4233
18. Kilic N., and Ergun S. Methods to evaluate the formation and stabilization of blood vessels and their role in tumor growth and metastasis. In: Brooks S.A., and Schumacher U. (Eds). Methods in Molecular Medicine: Metastasis Research Protocols, Cell Behavior In Vitro and In Vivo. 2nd ed. (2001), Humana Press, Totowa, NJ 125-148
19. Singer B.B., Klaile E., Scheffrahn I., et al. CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes. Eur J Immunol 35 (2005) 1949-1959
20. Lin S.H., and Pu Y.S. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer. Semin Oncol 26 (1999) 227-233
21. Nollau P., Scheller H., Kona-Horstmann M., et al. Expression of CD66a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas. Cancer Res 57 (1997) 2354-2357
22. Riethdorf L., Lisboa B.W., Henkel U., Naumann M., Wagener C., and Loning T. Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem 45 (1997) 957-963
23. Kleinerman D.I., Dinney C.P., Zhang W.W., Lin S.H., Van N.T., and Hsieh J.T. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res 56 (1996) 3431-3435
24. Kunath T., Ordonez-Garcia C., Turbide C., and Beauchemin N. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 11 (1995) 2375-2382
25. Luo W., Wood C.G., Earley K., Hung M.C., and Lin S.H. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Oncogene 14 (1997) 1697-1704
26. Tilki D., Oliveira-Ferrer L., Kilic N., Friedrich M.G., Stief C.G., and Ergun S. One molecule, two faces. Epithelial loss of cell adhesion molecule CEACAM1 activates angiogenesis in bladder and prostate cancer. Urologe A 46 (2007) 1128-1134
27. Volpert O., Luo W., Liu T.J., Estrera V.T., Logothetis C., and Lin S.H. Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J Biol Chem 277 (2002) 35696-35702
28. Simeone D.M., Ji B., Banerjee M., et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 34 (2007) 436-443
29. Bensalah K., Montorsi F., and Shariat S.F. Challenges of cancer biomarker profiling. Eur Urol 52 (2007) 1601-1609
30. Shariat S.F., Karam J.A., and Lerner S.P. Molecular markers in bladder cancer. Curr Opin Urol 18 (2008) 1-8